Vascular Graft Market Size (2024 - 2029)

Vascular Graft Market Analysis

The Vascular Graft Market is expected to register a CAGR of 5.70% during the forecast period.

Key factors driving market growth include the increasing number of dialysis procedures and rising chronic kidney disease (CKD) cases globally. As per the article published in the journal Kidney International Supplements in April 2022, chronic kidney disease, a progressive condition, affected over 10% of the general population worldwide, accounting for more than 800 million individuals. Moreover, the prevalence of cardiovascular diseases, diabetes, and end-stage renal disease is also expected to drive the market. According to CDC data updated in July 2022, coronary heart disease was the most common type of heart disease, and approximately 20.1 million adults aged 20 and older were diagnosed with the disease in the United States. Since there are more chronic diseases worldwide, there is a need for vascular grafts, which is expected to drive the growth of the market over the next few years.

Moreover, according to data published in April 2022 by the CDC, more than 795,000 people were affected by strokes in the United States each year. About 185,000 of these strokes, or roughly one in four, occurred in people who already had a stroke, and approximately 610,000 of them were first or recurrent strokes. As the number of strokes goes up, the demand for effective treatments like coronary artery by-pass surgery and better cardiovascular devices is expected to increase. This is expected to drive market growth over the forecast period.

Furthermore, an increase in research studies demonstrating the benefits of vascular grafts for various chronic diseases is further likely to propel market growth over the forecast period. For instance, according to an article published by researchers in the United States in January 2023 in the Biofabrication journal, the genipin-crosslinked DAM graft showed improved integrated structure, prolonged stability, proper mechanical properties, and superior biocompatibility. Hence, such research developments are likely to offer significant acceptance for advanced vascular grafts, leading to market growth over the forecast period.

However, in emerging economies, a low rate of reimbursement and rising out-of-pocket costs can slow market growth.

Vascular Graft Industry Segmentation

As per the scope of the report, vascular grafts are medical devices used in vascular by-pass procedures to direct the blood flow from one area to another by reconnecting the blood vessels.

The vascular graft market is segmented by product, application, raw material and geography. By product, the market is segmented into hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery by-pass grafts. By application, the market is segmented into aneurysms, kidney failures, vascular occlusions, coronary artery diseases, and other applications. By raw material, the market is segmented into synthetic raw materials and biological raw materials. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also offers the market size and forecasts for ten countries across the region. For each segment, the market sizing and forecasts have been done on the basis of value (USD).